Fetal Alcohol Spectrum Disorder : Clinical Description and Search for Epigenetic Biomarker (EPI-TSAF)

NACompletedINTERVENTIONAL
Enrollment

188

Participants

Timeline

Start Date

June 12, 2024

Primary Completion Date

October 22, 2024

Study Completion Date

October 23, 2024

Conditions
Fetal Alcohol Spectrum Disorders
Interventions
DIAGNOSTIC_TEST

Extraction of microRNAs extracted from plasma (4 ml recovered as part of treatment)

Comparison of these micro RNAs with the micro RNAs extracted from oral swabs (in Fetal Alcohol Spectrum Disorder group)

DIAGNOSTIC_TEST

Extraction of microRNAs extracted from bucal swabs (act added for research).

Comparison of the microRNAs extracted from the oral swabs of the Fetal Alcohol Spectrum Disorder group with the microRNAs extracted from the oral swabs of the without Fetal Alcohol Spectrum Disorder group

Trial Locations (1)

97400

CHU de la Réunion, Saint-Denis

All Listed Sponsors
lead

Centre Hospitalier Universitaire de la Réunion

OTHER

NCT06471335 - Fetal Alcohol Spectrum Disorder : Clinical Description and Search for Epigenetic Biomarker (EPI-TSAF) | Biotech Hunter | Biotech Hunter